Gene · 3451
Papers2,506
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,506
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer Vaccine Therapeutics: Limitations and Effectiveness-A Literature Review. | Cells | 2023 | 37681891 | PubTator, text mining | PubMed |
| Upregulated SPAG6 correlates with increased STAT1 and is associated with reduced sensitivity of interferon-α response in BCR::ABL1 negative myeloproliferative neoplasms. | Cancer Sci | 2023 | 37681349 | PubTator, text mining | PubMed |
| HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases. | Mol Med | 2023 | 37667233 | PubTator, text mining | PubMed |
| Advancing Immunotherapies for HPV-Related Cancers: Exploring Novel Vaccine Strategies and the Influence of Tumor Microenvironment. | Vaccines (Basel) | 2023 | 37631922 | PubTator, text mining | PubMed |
| Autoimmune Heart Disease: A Comprehensive Summary for Forensic Practice. | Medicina (Kaunas) | 2023 | 37629654 | PubTator, text mining | PubMed |
| Correlation of Coagulation Dysfunction with Infection and Hypercapnia in Acute Exacerbation of COPD Patients. | Infect Drug Resist | 2023 | 37614682 | PubTator, text mining | PubMed |
| ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification. | J Biomed Sci | 2023 | 37608279 | PubTator, text mining | PubMed |
| Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation. | Front Immunol | 2023 | 37600811 | PubTator, text mining | PubMed |
| Simplifying complex antibody engineering using machine learning. | Cell Syst | 2023 | 37591204 | PubTator, text mining | PubMed |
| Immunotherapy as a Turning Point in the Treatment of Melanoma Brain Metastases. | Discoveries (Craiova) | 2023 | 37583899 | PubTator, text mining | PubMed |
| Influence of a Single Deuterium Substitution for Protium on the Frequency Generation of Different-Size Bubbles in IFNA17. | Int J Mol Sci | 2023 | 37569512 | PubTator, text mining | PubMed |
| Evolution of Vaccines Formulation to Tackle the Challenge of Anti-Microbial Resistant Pathogens. | Int J Mol Sci | 2023 | 37569427 | PubTator, text mining | PubMed |
| BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution. | Theranostics | 2023 | 37554265 | PubTator, text mining | PubMed |
| Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases. | World J Gastrointest Oncol | 2023 | 37546552 | PubTator, text mining | PubMed |
| Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma. | BMC Cancer | 2023 | 37543576 | PubTator, text mining | PubMed |
| Comprehensive analysis of ferritinophagy-related genes and immune infiltration landscape in diabetic retinopathy. | Front Endocrinol (Lausanne) | 2023 | 37522124 | PubTator, text mining | PubMed |
| Uncovering the first complete chloroplast genomics, comparative analysis, and phylogenetic relationships of the medicinal plants Rhamnus cathartica and Frangula alnus (Rhamnaceae). | Physiol Mol Biol Plants | 2023 | 37520808 | PubTator, text mining | PubMed |
| System Biology Approach to Identify the Hub Genes and Pathways Associated with Human H5N1 Infection. | Vaccines (Basel) | 2023 | 37515084 | PubTator, text mining | PubMed |
| Impact of Obesity and Diabetes in Pregnant Women on Their Immunity and Vaccination. | Vaccines (Basel) | 2023 | 37515062 | PubTator, text mining | PubMed |
| Hepatitis C Virus Down-Regulates the Expression of Ribonucleotide Reductases to Promote Its Replication. | Pathogens | 2023 | 37513740 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3451/papers?page=9